Showing results (251-260 of 2,132) with videos related to

Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|June 1, 2018
CBR1 rs9024 genotype status impacts the bioactivation of loxoprofen in human liverAdolfo Quiñones-Lombraña, Nasi Li, Virginia Del Solar, et al.
Biopharmaceutics & Drug Disposition|October 2, 2003
Bioequivalence evaluation of two brands of enalapril 20 mg tablets (Narapril and Renitec) in healthy human volunteersNaji M Najib, Nasir Idkaidek, Ayman Adel, et al.
Biopharmaceutics & Drug Disposition|July 1, 1992
'In vitro' action of histamine and cimetidine on amylase secretion in the rat pancreasL Jiménez Murillo, J Torre-Cisneros, A Blanco-Molina, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
Pharmacokinetics of alfuzosin after single oral administration to healthy volunteers, of three different dosesP Salva, G Bianchetti, P Morselli, et al.
Biopharmaceutics & Drug Disposition|November 1, 1992
The metabolism of CGS 15873 in man using stable isotope pattern recognition techniquesM Leal, M J Hayes, M L Powell
Biopharmaceutics & Drug Disposition|February 12, 2004
Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XLDenise Barilla, Pratapa Prasad, Martine Hubert, et al.
Biopharmaceutics & Drug Disposition|October 18, 2007
Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in ratsDong-Hyun Choi, Kyong-Sig Chang, Soon-Pyo Hong, et al.
Biopharmaceutics & Drug Disposition|October 18, 2007
New method for the simultaneous estimation of intrinsic hepatic clearance and protein binding by matrix inhibitionTakahide Uchimura, Motohiro Kato, Tatsuhiko Tachibana, et al.
Biopharmaceutics & Drug Disposition|October 18, 2007
Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary resultsBeatriz Bicalho, Juliana Marconi Giolo, Sergio Lilla, et al.
Pageof 214